trial · primary record
Mitapivat
Non-Transfusion-dependent Alpha-Thalassemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 45 |
| Primary completion | 2032-03 |
| Primary endpoint | Percentage of Participants Who Achieved a Hemoglobin (Hb) Response |
| Registry ID | NCT07517133 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:18.281Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07517133
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mitapivat · compound